Trevi Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.293; its P/E ratio is -9.15; Trevi Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -7.80M	$ -7.71M	$ -7.02M	$ -7.40M	$ -6.36M
EBITDA	$ -8.00M	-	$ -7.38M	$ -7.97M	$ -6.80M
Net Income Common Stockholders	$ -7.51M	$ -7.70M	$ -7.14M	$ -6.40M	$ -5.50M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 82.97M	$ 88.87M	$ 94.15M	$ 111.26M	$ 120.51M
Total Assets	$ 89.40M	$ 95.90M	$ 100.98M	$ 115.96M	$ 123.02M
Total Debt	$ 1.34M	$ 1.41M	$ 1.47M	$ 9.02M	$ 9.18M
Net Debt	$ -81.63M	$ -87.46M	$ -92.68M	$ -102.24M	$ -111.33M
Total Liabilities	$ 6.86M	$ 6.29M	$ 5.90M	$ 14.47M	$ 15.56M
Stockholders Equity	$ 82.55M	$ 89.61M	$ 95.07M	$ 101.73M	$ 107.46M
Cash Flow	-
Free Cash Flow	$ -6.38M	-	$ -9.91M	$ -8.25M	$ -6.45M
Operating Cash Flow	$ -6.36M	$ -7.28M	$ -9.88M	$ -8.20M	$ -6.33M
Investing Cash Flow	$ 12.85M	$ 17.98M	$ 19.64M	$ 8.96M	$ -48.31M
Financing Cash Flow	$ -54.00K	$ 1.51M	$ -7.66M	$ -1.70M	$ 652.00K

Currency in USD

Trevi Therapeutics Earnings and Revenue History

Income Statement >

Trevi Therapeutics Debt to Assets

Balance Sheet >

Trevi Therapeutics Cash Flow

Cash Flow >

Trevi Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing